Gemox versus surveillance following surgery of localized biliary tract cancer: Results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial.Julien Edeline, Éveline Boucher, Franck Bonnetain et al.|Journal of Clinical Oncology|2017Cited by 110
Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trialPhilippe Merle, Gabriele Luppi, François Habersetzer et al.|The Lancet. Gastroenterology & hepatology|2019Cited by 61
Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studiesJulien Edeline, Tomoki Ebata, Satoshi Hirano et al.|European Journal of Cancer|2022Cited by 38
55P Adjuvant gemcitabine-based chemotherapy for biliary tract cancer: Pooled analysis of the BCAT and PRODIGE-12 studiesJulien Edeline, Tomoki Ebata, Satoshi Hirano et al.|Annals of Oncology|2020Cited by 1